全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts

DOI: 10.1371/journal.pone.0033917

Full-Text   Cite this paper   Add to My Lib

Abstract:

While high-density lipoprotein (HDL) is known to protect against a wide range of inflammatory stimuli, its anti-inflammatory mechanisms are not well understood. Furthermore, HDL's protective effects against saturated dietary fats have not been previously described. In this study, we used endothelial cells to demonstrate that while palmitic acid activates NF-κB signaling, apolipoprotein A–I, (apoA-I), the major protein component of HDL, attenuates palmitate-induced NF-κB activation. Further, vascular NF-κB signaling (IL-6, MCP-1, TNF-α) and macrophage markers (CD68, CD11c) induced by 24 weeks of a diabetogenic diet containing cholesterol (DDC) is reduced in human apoA-I overexpressing transgenic C57BL/6 mice compared to age-matched WT controls. Moreover, WT mice on DDC compared to a chow diet display increased gene expression of lipid raft markers such as Caveolin-1 and Flotillin-1, and inflammatory Toll-like receptors (TLRs) (TLR2, TLR4) in the vasculature. However apoA-I transgenic mice on DDC show markedly reduced expression of these genes. Finally, we show that in endothelial cells TLR4 is recruited into lipid rafts in response to palmitate, and that apoA-I prevents palmitate-induced TLR4 trafficking into lipid rafts, thereby blocking NF-κB activation. Thus, apoA-I overexpression might be a useful therapeutic tool against vascular inflammation.

References

[1]  Murphy AJ, Woollard KJ (2010) High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 37: 710–718.
[2]  Getz GS, Wool GD, Reardon CA (2010) HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des 16: 3173–3184.
[3]  Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR (2011) Anti-atherogenic mechanisms of high density lipoprotein: Effects on myeloid cells. Biochim Biophys Acta.
[4]  Navab M, Reddy ST, Van Lenten BJ, Fogelman AM (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 8: 222–232.
[5]  Degoma EM, Rader DJ (2011) Novel HDL-directed pharmacotherapeutic strategies. Nat Rev Cardiol 8: 266–277.
[6]  Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ (1995) High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15: 1987–1994.
[7]  Park SH, Park JH, Kang JS, Kang YH (2003) Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression. Int J Biochem Cell Biol 35: 168–182.
[8]  Tolle M, Pawlak A, Schuchardt M, Kawamura A, Tietge UJ, et al. (2008) HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol 28: 1542–1548.
[9]  Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, et al. (1995) Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96: 2882–2891.
[10]  Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, et al. (2001) HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 21: 481–488.
[11]  Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, et al. (2008) ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118: 3701–3713.
[12]  Saemann MD, Poglitsch M, Kopecky C, Haidinger M, Horl WH, et al. (2010) The versatility of HDL: a crucial anti-inflammatory regulator. Eur J Clin Invest 40: 1131–1143.
[13]  Haas MJ, Mooradian AD (2011) Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis 24: 265–272.
[14]  Tang C, Liu Y, Kessler PS, Vaughan AM, Oram JF (2009) The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J Biol Chem 284: 32336–32343.
[15]  Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, et al. (2010) Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 51: 3196–3206.
[16]  Puranik R, Bao S, Nobecourt E, Nicholls SJ, Dusting GJ, et al. (2008) Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis 196: 240–247.
[17]  Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, et al. (2007) Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 322: 514–520.
[18]  Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, et al. (2008) L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res 49: 1658–1669.
[19]  Subramanian S, Han CY, Chiba T, McMillen TS, Wang SA, et al. (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28: 685–691.
[20]  Mendez AJ, Oram JF, Bierman EL (1991) Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266: 10104–10111.
[21]  Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, et al. (2007) Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 100: 1589–1596.
[22]  Kim F, Tysseling KA, Rice J, Pham M, Haji L, et al. (2005) Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta. Arterioscler Thromb Vasc Biol 25: 989–994.
[23]  Subramanian S, Han CY, Chiba T, McMillen TS, Wang SA, et al. (2008) Dietary Cholesterol Worsens Adipose Tissue Macrophage Accumulation and Atherosclerosis in Obese LDL Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol.
[24]  Fessler MB, Parks JS (2011) Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol 187: 1529–1535.
[25]  Triantafilou M, Lepper PM, Olden R, Dias IS, Triantafilou K (2011) Location, location, location: is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm 2011: 186093.
[26]  Triantafilou M, Miyake K, Golenbock DT, Triantafilou K (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603–2611.
[27]  Soong G, Reddy B, Sokol S, Adamo R, Prince A (2004) TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 113: 1482–1489.
[28]  Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98: 1352–1364.
[29]  Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, et al. (2008) High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28: 2071–2077.
[30]  Yvan-Charvet L, Welch C, Pagler TA, Ranalletta M, Lamkanfi M, et al. (2008) Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837–1847.
[31]  Murphy AJ, Woollard KJ, Suhartoyo A, Stirzaker RA, Shaw J, et al. (2011) Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arterioscler Thromb Vasc Biol 31: 1333–1341.
[32]  Van Linthout S, Spillmann F, Graiani G, Miteva K, Peng J, et al. (2011) Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl) 89: 151–160.
[33]  Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, et al. (2010) Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am J Physiol Cell Physiol 298: C1538–1548.
[34]  Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, et al. (2004) Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol 24: 98–105.
[35]  Fernandez-Hernando C, Yu J, Suarez Y, Rahner C, Davalos A, et al. (2009) Genetic evidence supporting a critical role of endothelial caveolin-1 during the progression of atherosclerosis. Cell Metab 10: 48–54.
[36]  Yang N, Ying C, Xu M, Zuo X, Ye X, et al. (2007) High-fat diet up-regulates caveolin-1 expression in aorta of diet-induced obese but not in diet-resistant rats. Cardiovasc Res 76: 167–174.
[37]  Razani B, Combs TP, Wang XB, Frank PG, Park DS, et al. (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 277: 8635–8647.
[38]  Tiruppathi C, Shimizu J, Miyawaki-Shimizu K, Vogel SM, Bair AM, et al. (2008) Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 283: 4210–4218.
[39]  Kim SJ, Choi Y, Choi YH, Park T (2011) Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem.
[40]  Chen JX, Stinnett A (2008) Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Invest 88: 1316–1328.
[41]  Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, et al. (2009) Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 284: 27384–27392.
[42]  Bursill CA, Castro ML, Beattie DT, Nakhla S, van der Vorst E, et al. (2010) High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler Thromb Vasc Biol 30: 1773–1778.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133